President Donald Trump has announced that prescription drug and pharmaceutical prices in the United States will be reduced almost immediately. This statement was made following a weekend of trade talks with China, which were described as positive but lacked concrete details. In contrast, Trump's comments on drug prices are being presented as more substantive, especially for Americans who depend on medications for their health. The president did not provide specific information on how these reductions would be achieved, nor did he outline a timeline or policy measures. The issue of high prescription drug prices has been a significant concern in the US, with many citizens struggling to afford essential medications. Previous efforts by the Trump administration have included proposals to increase price transparency and allow the importation of cheaper drugs from abroad. However, the pharmaceutical industry has often pushed back against such measures, citing concerns about innovation and safety. As of now, it remains to be seen how and when the promised price reductions will take effect, and whether they will be implemented through executive action, legislation, or negotiations with pharmaceutical companies.